Christoph Abé1, Carl-Johan Ekman1, Carl Sellgren1, Predrag Petrovic1, Martin Ingvar1, Mikael Landén1. 1. From the Departments of Clinical Neuroscience (Abé, Ekman, Petrovic, Ingvar, Landén), Physiology and Pharmacology (Sellgren), and Medical Epidemiology and Biostatistics (Landén), Karolinska Institutet, Stockholm, Sweden; and the Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the Gothenburg University, Gothenburg, Sweden (Landén).
Abstract
BACKGROUND: Bipolar disorder (BD) is a common chronic psychiatric disorder mainly characterized by episodes of mania, hypomania and depression. The disorder is associated with cognitive impairments and structural brain abnormalities, such as lower cortical volumes in primarily frontal brain regions than healthy controls. Although bipolar disorder types I (BDI) and II (BDII) exhibit different symptoms and severity, previous studies have focused on BDI. Furthermore, the most frequently investigated measure in this population is cortical volume. The aim of our study was to investigate abnormalities in patients with BDI and BDII by simultaneously analyzing cortical volume, thickness and surface area, which yields more information about disease- and symptom-related neurobiology. METHODS: We used MRI to measure cortical volume, thickness and area in patients with BDI and BDII as well as in healthy controls. The large study cohort enabled us to adjust for important confounding factors. RESULTS: We included 81 patients with BDI, 59 with BDII and 85 controls in our analyses. Cortical volume, thickness and surface area abnormalities were present in frontal, temporal and medial occipital regions in patients with BD. Lithium and antiepileptic drug use had an effect on the observed differences in medial occipital regions. Patients with the subtypes BDI and BDII displayed common cortical abnormalities, such as lower volume, thickness and surface area than healthy controls in frontal brain regions but differed in temporal and medial prefrontal regions, where only those with BDI had abnormally low cortical volume and thickness. LIMITATIONS: The group differences can be explained by progressive changes, but also by premorbid conditions. They could also have been influenced by unknown factors, such as social, environmental or genetic factors. CONCLUSION: Our findings suggest diagnosis-related neurobiological differences between the BD subtypes, which could explain distinct symptoms and point to potential biomarkers that could inform the subtype diagnosis of BD.
BACKGROUND:Bipolar disorder (BD) is a common chronic psychiatric disorder mainly characterized by episodes of mania, hypomania and depression. The disorder is associated with cognitive impairments and structural brain abnormalities, such as lower cortical volumes in primarily frontal brain regions than healthy controls. Although bipolar disorder types I (BDI) and II (BDII) exhibit different symptoms and severity, previous studies have focused on BDI. Furthermore, the most frequently investigated measure in this population is cortical volume. The aim of our study was to investigate abnormalities in patients with BDI and BDII by simultaneously analyzing cortical volume, thickness and surface area, which yields more information about disease- and symptom-related neurobiology. METHODS: We used MRI to measure cortical volume, thickness and area in patients with BDI and BDII as well as in healthy controls. The large study cohort enabled us to adjust for important confounding factors. RESULTS: We included 81 patients with BDI, 59 with BDII and 85 controls in our analyses. Cortical volume, thickness and surface area abnormalities were present in frontal, temporal and medial occipital regions in patients with BD. Lithium and antiepileptic drug use had an effect on the observed differences in medial occipital regions. Patients with the subtypes BDI and BDII displayed common cortical abnormalities, such as lower volume, thickness and surface area than healthy controls in frontal brain regions but differed in temporal and medial prefrontal regions, where only those with BDI had abnormally low cortical volume and thickness. LIMITATIONS: The group differences can be explained by progressive changes, but also by premorbid conditions. They could also have been influenced by unknown factors, such as social, environmental or genetic factors. CONCLUSION: Our findings suggest diagnosis-related neurobiological differences between the BD subtypes, which could explain distinct symptoms and point to potential biomarkers that could inform the subtype diagnosis of BD.
Authors: Kristine B Walhovd; Anders M Fjell; Anders M Dale; Bruce Fischl; Brian T Quinn; Nikos Makris; David Salat; Ivar Reinvang Journal: Neuroimage Date: 2006-03-15 Impact factor: 6.556
Authors: Carol Jahshan; Jonathan K Wynn; Amanda McCleery; David C Glahn; Lori L Altshuler; Michael F Green Journal: J Psychiatr Res Date: 2014-01-02 Impact factor: 4.791
Authors: Anne Duffy; Tomas Hajek; Martin Alda; Paul Grof; Robert Milin; Glenda MacQueen Journal: Eur Arch Psychiatry Clin Neurosci Date: 2009-04-23 Impact factor: 5.270
Authors: T Hajek; M Bauer; C Simhandl; J Rybakowski; C O'Donovan; A Pfennig; B König; A Suwalska; K Yucel; R Uher; L T Young; G MacQueen; M Alda Journal: Psychol Med Date: 2013-05-31 Impact factor: 7.723
Authors: Joseph J Shaffer; Casey P Johnson; Jess G Fiedorowicz; Gary E Christensen; John A Wemmie; Vincent A Magnotta Journal: Brain Imaging Behav Date: 2018-06 Impact factor: 3.978
Authors: Meichen Yu; Nicholas Cullen; Kristin A Linn; Desmond J Oathes; Darsol Seok; Philip A Cook; Romain Duprat; Irem Aselcioglu; Tyler M Moore; Christos Davatzikos; Maria A Oquendo; Myrna M Weissman; Russell T Shinohara; Yvette I Sheline Journal: Mol Psychiatry Date: 2021-02-15 Impact factor: 13.437